Table 1 Patient baseline characteristics
N = 50 | |
|---|---|
Male, n (%) | 22 (44.0) |
Age (years) | 47.5 ± 14.8* |
Ever smoker, n (%) | 14 (28.0) |
Disease duration (months) | 57.1 ± 55.1* |
Extra-intestinal organ system involvement, n (%)** | 36 (72.0) |
History of tuberculosis, n (%) | 2 (4.0) |
Concomitant diseases, n (%) *** | 36 (72.0) |
Concomitant medications, n (%) | 46 (92.0) |
5-aminosalicylic acids or sulfasalazine | 36 (72.0) |
Systemic corticosteroids | 29 (58.0) |
Non-steroidal anti-inflammatory drugs | 10 (20.0) |
Immunosuppressants | 22 (44.0) |
Previous treatment for BD, n (%) | 46 (92.0) |
5-aminosalicylic acids and sulfasalazine, n (%) | 42 (84.0) |
Systemic corticosteroids, n (%) | 40 (80%) |
Immunomodulators, n (%) | |
Azathioprine, n (%) | 27 (54.0) |
Methotrexate, n (%) | 8 (16.0) |
Previous biologics treatment, n (%) | 10 (20.0) |
Infliximab, n (%) | 10 (20.0) |